Glassman Wealth Services’s Assembly Biosciences ASMB Stock Holding History

Glassman Wealth Services’s Portfolio ASMB Stock Details ASMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1	Closed	–	–	1064
2019 Q1	$0	Buy	+1	New	+$253	﹤0.01%	1022

Other funds holding ASMB

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Glassman Wealth Services's ASMB Position: Q2 2019 in Review

Glassman Wealth Services sold out of Assembly Biosciences (ASMB) in Q2 2019, closing a stake of 1 share.

Glassman Wealth Services first reported a position in ASMB in Q1 2019 and held it in 1 quarter. The position peaked at $0 in Q1 2019. 106 funds tracked by Wall St. Rank hold ASMB as of Q2 2019.

Glassman Wealth Services reported no remaining Assembly Biosciences position as of Q2 2019 after selling out during the quarter.
Glassman Wealth Services sold 1 Assembly Biosciences share in Q2 2019.
Glassman Wealth Services first reported a position in Assembly Biosciences in Q1 2019 and held it in 1 quarter.
Glassman Wealth Services's Assembly Biosciences position peaked at $0 in Q1 2019.
106 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2019.

Based on Glassman Wealth Services's 13F filing for Q2 2019, filed 8 Aug 2019.